𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does improved insulin sensitivity by irbesartan at the highest tolerated dose provide a benefit in non-diabetic patients with systolic heart failure already receiving standardized treatment?

✍ Scribed by Yang, Dan; Liu, Zhihong


Book ID
123246838
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
131 KB
Volume
168
Category
Article
ISSN
0167-5273

No coin nor oath required. For personal study only.